Clinical Trial Update: REMAP ECMO - Beta Receptor Modulation Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for REMAP ECMO investigates beta receptor modulation in patients with heart failure and cardiogenic shock; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure

Drugs mentioned

• Beta receptor modulation agent (investigational)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Heart Failure, Cardiogenic Shock | Phase 2 | Status: RECRUITING